Stock Events

Stock Events

Nexalin Technology 

$2.53
55
+$0.08+3.25% 10:23 Today

Statistics

Day High
2.4
Day Low
2.4
52W High
50.7
52W Low
2.1
Volume
367
Avg. Volume
-
Mkt Cap
2.57M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Apr 2007
$9.38
Jan 2007
$9.38
Oct 2006
$9.38
Jul 2006
$9.38
Apr 2006
$9.38
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Dec 2Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-3.18
-2.15
-1.13
-0.1
Expected EPS
-2.91
Actual EPS
N/A

Financials

-2,722.19%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
302,000Revenue
-8.22MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NXL. It's not an investment recommendation.
NVIDIA
6
NVDA
YieldMax MSTR Option Income Strategy
6
MSTY
Microsoft
5
MSFT
Amazon
5
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap16.84B
Zimmer Biomet Holdings, Inc. competes in the medical devices sector, offering products that could be seen as alternatives to Nexalin's technology for treating conditions like anxiety and depression.
Medtronic
MDT
Mkt Cap110.49B
Medtronic plc is a global leader in medical technology, services, and solutions, including neuromodulation devices that compete with Nexalin's offerings.
Abbott Laboratories
ABT
Mkt Cap168.71B
Abbott Laboratories operates in various segments, including neuromodulation, making it a competitor in the market for therapeutic devices similar to Nexalin's.
Boston Scientific
BSX
Mkt Cap61.74B
Boston Scientific Corporation is involved in the development, manufacturing, and marketing of medical devices that compete in the neuromodulation space.
Smith & Nephew
SNN
Mkt Cap11.06B
Smith & Nephew plc offers medical devices that can be used in treatments that compete with Nexalin's technology, particularly in the area of pain management and rehabilitation.
Stryker
SYK
Mkt Cap105.65B
Stryker Corporation is a technology company that offers products in medical and surgical, which could compete with Nexalin's approach to treating neurological conditions.
Edwards Lifesciences
EW
Mkt Cap49.08B
Edwards Lifesciences Corporation is known for its innovations in patient-focused medical technologies, including those that could compete with Nexalin's neuromodulation devices.
Integra Lifesciences
IART
Mkt Cap986.16M
Integra LifeSciences Holdings Corporation offers products in neurosurgery and other medical device areas, potentially competing with Nexalin's technology.
Globus Medical
GMED
Mkt Cap10.15B
Globus Medical, Inc. is engaged in the design, development, and commercialization of musculoskeletal solutions, which may indirectly compete with Nexalin's neuromodulation therapies for pain management.

About

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
Show More
CEO
Mark White
Employees
8
Country
United States
ISIN
US65345B3006

Listings

XNAS
US
NXL
BOATS
BOATS
NXL.BOATS

0 Comments

Share your thoughts

FAQs

What is Nexalin Technology stock price today?▼
The current price of NXL is $2.53 USD — it has increased by +3.25% in the past 24 hours. Watch Nexalin Technology stock price performance more closely on the chart.
What is Nexalin Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Nexalin Technology stocks are traded under the ticker NXL.
Is Nexalin Technology stock price growing?▼
NXL stock has fallen by -32.51% compared to the previous week, the month change is a -50.2% fall, over the last year Nexalin Technology has showed a -93.86% decrease.
What is Nexalin Technology market cap?▼
Today Nexalin Technology has the market capitalization of 2.57M
When is the next Nexalin Technology earnings date?▼
Nexalin Technology is going to release the next earnings report on December 2, 2026.
What were Nexalin Technology earnings last quarter?▼
NXL earnings for the last quarter are -3.18 USD per share, whereas the estimation was -3 USD resulting in a -6% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nexalin Technology revenue for the last year?▼
Nexalin Technology revenue for the last year amounts to 302,000 USD.
What is Nexalin Technology net income for the last year?▼
NXL net income for the last year is -8.22M USD.
Does Nexalin Technology pay dividends?▼
Yes, NXL dividends are paid quarterly. The last dividend per share was 9.38 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Nexalin Technology have?▼
As of October 16, 2026, the company has 8 employees.
In which sector is Nexalin Technology located?▼
Nexalin Technology operates in the Health & Wellness sector.
When did Nexalin Technology complete a stock split?▼
The last stock split for Nexalin Technology was on August 31, 2026 with a ratio of 1:30.
Where is Nexalin Technology headquartered?▼
Nexalin Technology is headquartered in HOUSTON, United States.